A Biochemical Society Scientific Meeting
The PI 3-kinase (PI3K) pathway is an intracellular signalling pathway at the crossroads of cell signalling and vesicular traffic. The Biochemical Society last organised a meeting on this topic in 2006 and, since then, the PI3K field has massively expanded. After some challenging years in PI3K pathway drug development, good progress has recently been made, with three PI3K inhibitors now approved for oncology and several others in the registration pipeline.
This meeting focuses on the biology and signalling of the class I isoforms of PI3K, and the drugs that have been generated to interfere with their function in disease. We have invited speakers who bridge the gap between basic science and translation, as well as industry speakers to provide an update on their PI3K programmes and clincians who have been running clincial trials in this area.
- Provide networking opportunities for the UK/EU PI3K community and beyond
- Connect currently dispersed fields which have a common ground in PI3K
- Provide an update on the latest discoveries in the PI3K field, with a focus on understanding the basic biology and signalling, the disease state and translational opportunities
- Provide a networking opportunity for early career researchers
Continuing Professional Development (CPD)
This event is approved by the Royal Society of Biology for purposes of CPD
and may be counted as 72 CPD credits